ACCENDRA HEALTH INC/VA/ 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million and expires in February 2027. Under the program, we may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions and 10b5-1 trading plans . ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (in thousands, except per share data) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Period ​ Total Number of Shares Purchased ​ ​ Average Price Paid Per Share ​ Total Number of Shares Purchased as Part of Publicly Announced Program (1) ​ ​ Approximate Dollar Value of Shares That May Yet be Purchased Under the Program (2) February 26-February 28, 2025 ​ — ​ $ — ​ — ​ $ 100,000 March 1-March 31, 2025 ​ 173 ​ $ 8.66 ​ 173 ​ $ 98,500 April 1-April 30, 2025 ​ 653 ​ $ 7.87 ​ 653 ​ $ 93,360 May 1-May 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 June 1-June 30, 2025 ​ — ​ $ — ​ — ​ $ 93,360 July 1-July 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 August 1-August 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 September 1-September 30, 2025 ​ — ​ $ — ​ — ​ $ 93,360 Year-to-date ​ 826 ​ ​ ​ ​ 826 ​ ​ ​ ​ (1) On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million and expires in February 2027. Under the program, we may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions and 10b5-1 trading plans . (2) During the nine months ended September 30, 2025, we repurchased in open-market transactions and retired approximately 826 thousand shares of our common stock for an aggregate of $6.6 million, or an average price per share of $8.04.